DDInter948 DDInter1274
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
Nefazodone hydrochloride (trade name Serzone) is an antidepressant drug marketed by Bristol-Myers Squibb. Its sale was discontinued in 2003 in some countries, due to the small possibility of hepatic (liver) injury. Drug-induced hepatic injuries were associated with an risk of elevated need for a liver transplant, or even death, with the incidence of severe liver damage was shown to be approximately 1 in 250,000 to 300,000 patient-years. On May 20, 2004, Bristol-Myers Squibb discontinued the sale of Serzone in the United States.
Nefazodone {u} (Compound) resembles {v} (Compound) Hydroxyzine
Nefazodone {u} (Compound) resembles {v} (Compound) Trifluoperazine
Nefazodone {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Cetirizine
Nefazodone {u} (Compound) binds {v} (Gene) CYP3A4
Nefazodone {u} (Compound) upregulates {v} (Gene) SERPINA3
Nefazodone {u} (Compound) palliates {v} (Disease) endogenous depression
Nefazodone {u} (Compound) downregulates {v} (Gene) ADI1
Nefazodone {u} (Compound) causes {v} (Side Effect) Laryngitis
Nefazodone {u} may cause a minor interaction that can limit clinical effects when taken with {v} Darolutamide
Nefazodone {u} may cause a minor interaction that can limit clinical effects when taken with {v} Bexarotene
Nefazodone (Compound) resembles Hydroxyzine (Compound)
Nefazodone (Compound) resembles Trifluoperazine (Compound)
Nefazodone may cause a moderate interaction that could exacerbate diseases when taken with Cetirizine
Nefazodone (Compound) binds CYP3A4 (Gene)
Nefazodone (Compound) upregulates SERPINA3 (Gene)
Nefazodone (Compound) palliates endogenous depression (Disease)
Nefazodone (Compound) downregulates ADI1 (Gene)
Nefazodone (Compound) causes Laryngitis (Side Effect)
Nefazodone may cause a minor interaction that can limit clinical effects when taken with Darolutamide
Nefazodone may cause a minor interaction that can limit clinical effects when taken with Bexarotene